Orsight Pharma

Neovascular Age-Related Macular Degeneration Drug Treatment

Health Tech & Life Sciences
Active
Pre-Seed Nazareth, Israel Founded 2023
LinkedIn
Last updated 2026-06-18
Total raised
$2.1M
Last: Grant 2024-05
Stage
Pre-Seed
Founded
2023
Headcount
2
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences

About

Orsight Pharma develops a breakthrough small molecule treatment designed to preserve vision and prevent blindness through a novel VEGF-independent mechanism. This drug offers a ray of hope, especially for those who have not seen satisfactory results with existing treatments. The company's product not only stands to benefit patients unresponsive to current therapies but also has the potential to enhance visual outcomes when used in combination with them.

Funding history · 2 rounds · $2.1M total

2024-05
Grant Undisclosed
2023-01

Q&A

What is Orsight Pharma's primary focus?
Orsight Pharma is developing a breakthrough small molecule treatment for Neovascular Age-Related Macular Degeneration, aiming to preserve vision and prevent blindness through a novel VEGF-independent mechanism.
When was Orsight Pharma founded?
Orsight Pharma was founded in October 2023.
How many employees does Orsight Pharma currently have?
Orsight Pharma has 1-10 employees.
What is Orsight Pharma's current funding stage?
Orsight Pharma is currently in the Pre-Seed funding stage.
Who is a co-founder and CTO at Orsight Pharma?
Mariana Truman is a Co-founder and CTO at Orsight Pharma.
What was Orsight Pharma's total amount raised in USD?
Orsight Pharma has raised a total of $2,100,000 USD.
Which investor participated in Orsight Pharma's funding round in January 2023?
NGT HealthCare II participated in Orsight Pharma's funding round in January 2023.
Did Orsight Pharma receive any grants recently?
Yes, Orsight Pharma received a Grant in May 2024 from the Israel Innovation Authority.

Team · 1

Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Business model
B2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)